Upreti G C, Hinsdill R D
Antimicrob Agents Chemother. 1973 Oct;4(4):487-94. doi: 10.1128/AAC.4.4.487.
Nearly 100 isolates of Lactobacillus were obtained from human and animal sources. Screening tests with the isolates revealed seven possible bacteriocinogenic strains and 26 strains sensitive to one or more of these inhibitory strains. Three homofermentative strains were selected for additional study after it was shown that their inhibitory substances differed in activity spectrum and in susceptibility to inactivation by proteolytic enzymes. One of these, L. helveticus strain LP27, was shown to produce a potent bacteriocin called lactocin 27. The lactocin was isolated from the culture supernatant fluid as a protein-lipopolysaccharide complex. In the presence of sodium dodecyl sulfate the complex was dissociated, and the activity was found to reside in a small glycoprotein (molecular weight 12,400). The amino acid composition of purified lactocin 27 is similar to that of the L. fermenti bacteriocin; neither requires disulfide bonds for activity.
从人和动物源中获得了近100株乳酸杆菌分离株。对这些分离株进行的筛选试验显示有7株可能产生细菌素的菌株以及26株对这些抑制性菌株中的一种或多种敏感的菌株。在表明三种同型发酵菌株的抑制物质在活性谱和对蛋白水解酶失活的敏感性方面存在差异后,选择了这三种菌株进行进一步研究。其中之一,瑞士乳杆菌LP27菌株,被证明能产生一种名为乳酸杆菌素27的强效细菌素。乳酸杆菌素作为一种蛋白质 - 脂多糖复合物从培养上清液中分离出来。在十二烷基硫酸钠存在的情况下,该复合物解离,发现活性存在于一种小的糖蛋白中(分子量为12,400)。纯化的乳酸杆菌素27的氨基酸组成与发酵乳杆菌细菌素的相似;两者的活性都不需要二硫键。